Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    19812802 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Magnetic Resonance Imaging-Portfolio Diet Study #7
Conditions: Cardiovascular Diseases;   Hypercholesterolemia;   Diabetes;   Metabolic Syndrome;   Obesity
Interventions: Behavioral: Portfolio Plus Diet;   Behavioral: DASH-like (high fibre) dietary advice
2 Active, not recruiting TRANSforming InTerprofessional Cardiovascular Prevention in Primary Care
Conditions: Diabetes Mellitus, Type 2;   Hypertension;   Dyslipidemias;   Cholesterol, LDL;   Comorbitdity
Interventions: Other: Facilitation;   Other: Passive diffusion (usual implementation strategy)
3 Suspended Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring
Conditions: Cardiovascular Disease;   Cardiovascular Outcomes;   Kidney Transplant Recipients;   Kidney Transplantation
Interventions: Drug: Myfortic®;   Drug: Neoral®;   Drug: Cellcept®;   Drug: Prednisone
4 Recruiting Flax Muffins and Cholesterol Lowering
Condition: Above Optimal Plasma LDL Concentrations
Intervention: Other: muffin

Indicates status has not been verified in more than two years